Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $234,026.10 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 10,131 shares of OrthoPediatrics stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $23.10, for a total value of $234,026.10. Following the sale, the insider directly owned 6,526,633 shares in the company, valued at approximately $150,765,222.30. This trade represents a 0.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

OrthoPediatrics Trading Down 0.9%

Shares of KIDS opened at $22.59 on Friday. The stock’s 50-day moving average price is $21.74 and its 200 day moving average price is $18.84. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $589.82 million, a price-to-earnings ratio of -13.45 and a beta of 0.99. OrthoPediatrics Corp. has a 12-month low of $14.42 and a 12-month high of $26.74.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.04. The company had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%. As a group, research analysts predict that OrthoPediatrics Corp. will post -1.14 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Millennium Management LLC lifted its holdings in shares of OrthoPediatrics by 48.0% during the fourth quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock valued at $24,802,000 after acquiring an additional 452,840 shares during the period. BlackRock Inc. bought a new stake in shares of OrthoPediatrics in the 2nd quarter worth about $24,347,000. Vanguard Group Inc. grew its holdings in shares of OrthoPediatrics by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 961,330 shares of the company’s stock worth $17,813,000 after purchasing an additional 10,927 shares during the last quarter. Granahan Investment Management LLC increased its position in shares of OrthoPediatrics by 35.1% during the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock worth $14,231,000 after purchasing an additional 232,760 shares in the last quarter. Finally, Wasatch Advisors LP increased its position in shares of OrthoPediatrics by 56.6% during the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock worth $9,865,000 after purchasing an additional 186,357 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

KIDS has been the topic of several analyst reports. Truist Financial set a $22.00 price target on shares of OrthoPediatrics in a report on Wednesday, August 5th. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. TD Cowen reiterated a “buy” rating on shares of OrthoPediatrics in a research report on Monday, June 15th. BTIG Research increased their price target on shares of OrthoPediatrics from $24.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, August 20th. Finally, Needham & Company LLC raised their price target on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $26.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.